Zydus, supported by the Gates Foundation, to develop the world's first combination vaccine for shigellosis and typhoid in infants and children

Zydus Lifesciences Ltd, a global lifesciences company, announced its focus on the development of a combination vaccine against shigellosis and typhoid, aiming to protect children below 5 years in areas where both diseases are endemic. The project is expected to start in March 2025, supported by the Gates Foundation. The TCV-Shigella combination vaccine, if successful, will offer a viable solution for increasingly crowded, expensive, and unsustainable childhood immunization schedules.